Paul Choi
#1674 out of 1697 analysts
Goldman Sachs
Automatically Tracked
Analyst ratings are aggregated from multiple third-party sources and may be inaccurate, incomplete, or outdated. All ratings remain the sole responsibility of their original providers. Rankings are based on the 3-year performance of a simulated $100,000 account trading on analyst ratings data.
Gain and growth charts are calculated per selected timeframe:
-74.82%
Gain +23.65%
Monthly
-3.47%
Yearly
-34.52%
Drawdown
95.91%
$8,356.49
Equity
Holdings
$8,184.45
Cash
$172.04
Investment
$6,485.25
-$91,815.55
Profit +$1,595.89
Realized
-$93,514.75
Unrealized
$1,699.2
Dividends
$0
$172.04
Cash
Deposits
$100,172.04
Withdrawals
$0
Commissions
$0
Goals
Avg. 0% completed goals
Today
Compared To Yesterday
Gain
23.65%
Profit
$1,595.89
Win %
100%
This Week
Compared To Last Week
Gain
16.82%
Profit
$1,203.34
Win %
66%
This Month
Compared to last month
Gain
16.17%
Profit
$1,163.41
Win %
50%
This Year
Compared to last year
Gain
-7.98%
Profit
-$724.17
Win %
55%
KNSA Kiniksa Pharmaceuticals International, plc
+25.03%
+$1,638.64 No Data
Events
Loading...
Dividends
Dividend Analysis
Loading...
No Data
| Trades 214 | Longs Won 65/143 45% | Profit Factor 0.26 |
| Profitability | Shorts Won 35/71 49% | Standard Deviation $2,403.88 |
| Average Win $315.16 | Best Trade (Sep 01) $5,720.02 | Sharpe Ratio -160.2 |
| Average Loss -$1,081.86 | Worst Trade (Aug 20) -$23,547.96 | Z-Score -4.69 (100%) |
| Commissions $0 | Avg. Trade Length 1m 3w 5d | Expectancy -$429.04 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | - | - | - | - | - | - | - | - | - | - |
| Consecutive Losing Trades | 8 | 7 | 6 | 5 | 5 | 4 | 3 | 2 | 2 | 1 |
Hover over the desired column for a detailed explanation.
Returns
Overall, MonthlyNo Data
Option values are updated at end of day.
No Data
No Data
Option values are updated at end of day.
No Data
No Data
No Data
No Data
